Clinical Trials Browser

Phase 2/3 × Colorectal Neoplasms × folfirinox × Clear all

NCT00208260 2026-02-05

Intensified Chemotherapy in CRC After Resection of Liver Metastases

Phase 2/3 Completed

Gastrointestinal

Colorectal Neoplasms